Pacira BioSciences, Inc.

Pacira BioSciences, Inc.verified

PCRX

Price:

$19.2

Market Cap:

$886.53M

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira Bi...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2011-02-03

Stock Exchange

NASDAQ

Ticker

PCRX

The Current Ratio as of December 2024 (TTM) for Pacira BioSciences, Inc. (PCRX) is 2.25

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.25. This represents a change of -55.24% compared to the average of 5.03 of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical Current Ratio (quarterly & annually)

How has PCRX Current Ratio performed in the past?

The mean historical Current Ratio of Pacira BioSciences, Inc. over the last ten years is 4.01. The current 2.25 Current Ratio has changed 5.52% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Current Ratio was at its highest in in the March 2017 quarter at 9.81. The Current Ratio was at its lowest in in the December 2014 quarter at 1.53.

Quarterly (TTM)
Annual

Average

4.01

Median

3.58

Minimum

1.53

Maximum

7.88

Pacira BioSciences, Inc. (PCRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 225.56%

Maximum Annual Current Ratio = 7.88

Minimum Annual Increase = -51.84%

Minimum Annual Current Ratio = 1.53

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.2455.30%
20223.37102.92%
20211.66-35.39%
20202.57-32.21%
20193.79-51.84%
20187.8813.26%
20176.9628.33%
20165.42225.56%
20151.678.82%
20141.5374.81%

Pacira BioSciences, Inc. (PCRX) Average Current Ratio

How has PCRX Current Ratio performed in the past?

The current Current Ratio of Pacira BioSciences, Inc. (PCRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.42

5-year avg

3.33

10-year avg

4.01

Pacira BioSciences, Inc. (PCRX) Current Ratio vs. Peers

How is PCRX’s Current Ratio compared to its peers?

Pacira BioSciences, Inc.’s Current Ratio is less than Phibro Animal Health Corporation (3.23), greater than Dr. Reddy's Laboratories Limited (1.92), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Silver Spike Investment Corp. (0), less than Prestige Consumer Healthcare Inc. (3.56), less than HUTCHMED (China) Limited (2.81), less than Incannex Healthcare Limited (2.88), greater than Eagle Pharmaceuticals, Inc. (1.70), less than ANI Pharmaceuticals, Inc. (2.74), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Intra-Cellular Therapies, Inc. (7.66), less than Alkermes plc (3.45),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Pacira BioSciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Pacira BioSciences, Inc. (PCRX)?

What is the highest Current Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 3-year average Current Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 5-year average Current Ratio for Pacira BioSciences, Inc. (PCRX)?

How does the current Current Ratio for Pacira BioSciences, Inc. (PCRX) compare to its historical average?